Identification of cancer stem-like side population cells in ovarian cancer cell line OVCAR-3

Ultrastructural Pathology

Volumn 33, Issue 4, 2009, Pages 175-181

  Gao, Quanli ^a,b,c,d   Geng, Li ^a,c,d   Kvalheim, Gunnar ^e   Gaudernack, Gustav ^c,d   Suo, Zhenhe ^d,e  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b Henan Tumor Hospital   (China)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cancer stem cell; FACS; Immunocytochemistry; Oct3 4; OVCAR 3; RT PCR; Side population

Indexed keywords

HOE 33342; OCTAMER TRANSCRIPTION FACTOR 4; VERAPAMIL;

ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CELL CLONE; CELL LINE; CELL POPULATION; CELL SUBPOPULATION; CLONOGENIC ASSAY; COLONY FORMATION; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; OVARY CANCER; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIDE POPULATION CELL; STAINING;

BENZIMIDAZOLES; CELL LINE, TUMOR; FEMALE; FLOW CYTOMETRY; FLUORESCENT DYES; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASTIC STEM CELLS; OVARIAN NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STAINING AND LABELING; TUMOR MARKERS, BIOLOGICAL;

EID: 70149124370     PISSN: 01913123     EISSN: 15210758     Source Type: Journal    
DOI: 10.3109/01913120903086072     Document Type: Article

References (18)

1. Tu SM, Lin SH, Logothetis CJ. Stem-cell origin of metastasis and heterogeneity in solid tumors. Lancet Oncol. 2002;3:508-513.
2. Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature. 2001;415:105-111.
3. Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003;63:5821-5828.
4. O'Brien cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007;445:106-110.
5. Collins AT, Berry PA, Hyde C, et al. Prospective idntification of tum-origenic prostate cancer stem cells. Cancer Res. 2005;65:10946-10951.
6. Prince ME, Sivanandan R, Kaczorowski A, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA. 2007;104:973-978.
7. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 2003;100:3983-3988.
8. Zhang S, Balch C, Chan MW, et al. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res. 2008;68:4311-4320.
9. Shmelkov SV, Butler JM, Hooper AT, et al. CD133 expression is not restricted to stem cells, and both CD133 and CD133 metastatic colon cancer cells initiate tumors. J Clin Invest. 2008;118:2111-2120.
10. Mack B, Gires O. CD44 s and CD44v6 expression in head and neck epithelia. PLoS ONE. 2008;3:3360-3369.
11. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med. 1996;183:1797-1806.
12. Pecorelli S, Favalli G, Zigliani L, Odicino F. Cancer in women. Int J Gynaecol Obstet. 2003;82:369-379.
13. Moserle L, Indraccolo S, Ghisi M, et al. The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects. Cancer Res. 2008;68:5658-5668.
14. Wang Q, He W, Lu C, et al. Oct3/4 and Sox2 are significantly associated with an unfavorable clinical outcome in human squamous cell carcinoma. Anticancer Res. 2009;29:1233-1241.
15. Chiba T, Kita K, Zheng YW, et al. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology. 2006;44:240-251.
16. Huang D, Gao Q, Guo L, et al. Isolation and identification of cancer stem-like cells in esophageal carcinoma cell lines. Stem Cells Dev. 2009;18:93-101.
17. Zhou S, Schuetz JD, Bunting KD. The ABC transporter Bcrp1/ ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med. 2001;7:1028-1034.
18. Li H, Chen X, Calhoun-Davis T, et al. PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells. Cancer Res. 2008;68:1820-1825.